Therefore, whether the protective effect of ginsenoside Rg3 on diabetic cardiomyopathy completely depends on the adiponectin-mediated pathway remains to be further studied in conditional adipor-knockout mice. This evidence concerns the gene ADIPOQ and diabetic cardiomyopathy.